12.5 °C was observed for the duplex between the (almost) fully
modified oligonucleotide 5A-X13T-3A and complementary RNA.
These results indicate that these new 2A,3A-bicyclo oligonucleo-
tides (‘2A,3A-BcNAs’) form a duplex structure with com-
plementary RNA which is thermally significantly more stable
than the corresponding unmodified DNA–RNA duplex. The
structure of the duplex 2A,3A-BcNA–RNA is probably different
from that of wild type DNA–RNA as indicated by the
destabilising effect of one or two bicyclic nucleosides in an
otherwise unmodified DNA strand. The shapes of the circular
dichroism spectra, known to be diagnostic of a particular duplex
structure, recorded for T14 :rA14 and X13T:rA14 are, however,
similar. It is thus clear that conclusions about the structural basis
for the observed increase in thermal stability must await results
from other sequences and from extensive molecular modelling
and NMR studies.
Degradation by nucleases signifies a serious limitation to in
vivo application of both natural and many modified oligo-
nucleotides. We have therefore evaluated the novel 2A,3A-BcNA
(X13T) against snake venom phosphodiesterase (a 3A-exo-
nuclease) using a method described earlier.13 Whereas the
unmodified control (T14) is fully degraded within 10 min, X13T
(or X13) remains intact for the 60 min monitored. Thus, although
other nucleases need to be evaluated, this result suggests that
2A,3A-BcNAs may be effectively protected against nucleolytic
degradation.
We thank The Danish Natural Science Research Council for
financial support. Dr Carl Erik Olsen is thanked for recording
MALDI-MS.
Footnotes
† E-mail: wengel@kiku.dk
‡ Full characterisation of all intermediates will be published as part of a
forthcoming publication.
§ The structure of nucleoside 5 was verified from MS, 1H NMR, 13C NMR,
1H–1H COSY and NOE experiments. Selected data for 5: 1H NMR (250
MHz; [2H6]DMSO): d 11.3 (1 H, br s, NH), 7.36 (1 H, d, J 1.1, 6-H), 5.80
(1 H, d, J 4.3, 1A-H), 5.61 (1 H, s, OH), 4.86 (1 H, m, 5A-Ha), 3.89 (1 H, d,
J 4.2, 2A-H), 3.85 (1 H, m, 2B-H), 3.83–3.64 (3 H, m, 4A-H, 5A-Hb, 2B-H),
2.14 (1 H, m, 1B-H), 1.81 (1 H, m, 1B-H), 1.78 (3 H, d, J 1.0, Me); 13C NMR
(62.9 MHz; CD3OD): d 166.7 (C-4), 152.2 (C-2), 139.7 (C-6), 110.1 (C-5),
89.4, 89.1, 85.5, 85.2 (C-1A, C-2A, C-3A, C-4A), 71.4 (C-2B), 61.6 (C-5A), 37.0
(C-1B), 12.7 (Me) (Found: C, 47.4; H, 5.7; N, 9.0; C12H16N2O6·H2O
requires C, 47.7; H, 6.0; N, 9.3%). Mutual NOE contacts between H-1A and
H-2A and between H-1A and H-4A, as well as the lack of contacts between H-5A
and H-1A or H-2A and between H-2A and H-6, confirm the assigned b-arabino
configuration.
¶ The oligonucleotides were synthesised on a Pharmacia Gene Assembler in
0.2 mmol scale using commercial 2-cyanoethyl phosphoramidites (2 min
coupling time, ca. 99% stepwise yield) and the amidite derived from
nucleoside 5 (2 3 12 min coupling time, ca. 95% stepwise yield).
Purification of 5A-O-DMT-ON oligonucleotides was accomplished using
disposable reversed-phase chromatography cartridges (Cruachem Inc.),
which includes 5A-O-detritylation. The composition of the oligonucleotides
were verified by MALDI-MS and the purity by capillary gel electro-
phoresis. Minor peaks ( < 5%) originating from X10T, X11T and X12T were
detected when running X13T.
In conclusion, a new bicyclic thymidine analogue 5 has been
synthesised and used as a monomer to construct a novel class of
conformationally restricted 2A,3A-bicyclo oligonucleotides
(‘2A,3A-BcNAs’). Melting experiments revealed excellent ther-
mal stability of a 2A,3A-BcNA–RNA duplex, which, together
with the observed stability towards 3A-exo nucleolytic degrada-
tion, suggests 2A,3A-BcNAs to be interesting candidates as
antisense molecules.
References
1 R. W. Wagner, Nature, 1994, 372, 333; A. De Mesmaeker, R. Ha¨ner,
P. Martin and H. E. Moser, Acc. Chem. Res., 1995, 28, 366.
2 P. Herdewijn, Liebigs Ann. Chem., 1996, 1337.
3 M. Tarko¨y, M. Bolli, B. Schweizer and C. Leumann, Helv. Chim. Acta,
1993, 76, 481; M. Tarko¨y and C. Leumann, Angew. Chem., Int. Ed.
Engl., 1993, 32, 1432; M. Tarko¨y, M. Bolli and C. Leumann, Helv.
Chim. Acta, 1994, 77, 716; J. C. Litten and C. Leumann, Helv. Chim.
Acta, 1996, 79, 1129; M. Egli, P. Lubini, M. Dobler and C. Leumann,
J. Am. Chem. Soc., 1993, 115, 5855.
Table 1 Melting experiments of modified oligonucleotidesa
4 K.-H. Altmann, R. Kesselring, E. Francotte and G. Rihs, Tetrahedron
Lett., 1994, 35, 2331; K.-H. Altmann, R. Imwinkelried, R. Kesselring
and G. Rihs, Tetrahedron Lett., 1994, 35, 7625.
Complimentary ssDNA
(dA14
Complimentary
ssRNA (rA14
)
)
5 R. Zou and M. Matteucci, Tetrahedron Lett., 1996, 37, 941.
6 R. J. Jones, S. Swaminathan, J. F. Millagan, S. Wadwani, B. S. Froehler
and M. Matteucci, J. Am. Chem. Soc., 1993, 115, 9816.
7 A. van Aerschot, I. Verheggen, C. Hendrix and P. Herdewijn, Angew.
Chem., Int. Ed. Engl., 1995, 34, 1338.
8 Y. Yoshimura, T. Sano, A. Matsuda and T. Ueda, Chem. Pharm. Bull.,
1988, 36, 162.
9 P. Nielsen, K. Larsen and J. Wengel, Acta. Chem. Scand., 1996, 50,
1030.
10 J. J. Fox and N. C. Miller, J. Org. Chem., 1963, 28, 936.
11 H. Vorbru¨ggen, K. Krolikiewicz and B. Bennua, Chem. Ber., 1981, 114,
1234; H. Vorbru¨ggen and G. Ho¨fle, Chem. Ber., 1981, 114, 1256.
12 M. H. Caruthers, Acc. Chem. Res., 1991, 24, 278.
13 P. Nielsen, F. Kirpekar and J. Wengel, Nucleic Acids Res., 1994, 22,
703.
Oligonucleotide
Tm/°C
DTm/°C
Tm/°C
DTm/°C
5A-T14-3A
34.5
32.0
30.0
29.5
23.0
23.0
< 10
29.5
26.5
28.0
23.0
30.5
16.5
42.0
5A-T7XT6-3A
5A-T6X2T6-3A
5A-T6XTXT5-3A
5A-T5X4T5-3A
5A-T3(TX)4T3-3A
5A-X13T-3A
22.5
24.5
25.0
211.5
211.5
< 224
23.0
21.5
26.5
+1.0
213.0
+12.5
a Measured at 260 nm in medium salt buffer: 1 mm EDTA, 10 mm Na3PO4,
140 mm NaCl, pH 7.2; concentration of each strand: 1.0 mm; T = thymidine
monomer; dA = 2A-deoxyadenosine monomer; rA = adenosine monomer;
X = monomer derived from nucleoside 5; Tm = melting temperature
determined as the local maximum of the first derivative of the absorbance
vs. temperature curve; DTm = change in Tm compared to unmodified
controls.
Received in Glasgow, UK, 5th December 1996; Com.
6/08231I
826
Chem. Commun., 1997